Home/Filings/5/0001213900-25-006114
5//SEC Filing

STROME MARK E 5

Accession 0001213900-25-006114

CIK 0001101026other

Filed

Jan 22, 7:00 PM ET

Accepted

Jan 23, 7:48 PM ET

Size

12.3 KB

Accession

0001213900-25-006114

Insider Transaction Report

Form 5
Period: 2024-12-31
STROME MARK E
10% Owner
Transactions
  • Purchase

    Common Stock Purchase Warrant

    2024-08-27+3,00044,171 total(indirect: By entity)
    Exercise: $8.44From: 2024-08-27Exp: 2029-08-27Common Stock
  • Purchase

    Common Stock

    2024-08-27$8.44/sh+30,000$253,200398,683 total(indirect: By entity)
Transactions
  • Purchase

    Common Stock

    2024-08-27$8.44/sh+30,000$253,200398,683 total(indirect: By entity)
  • Purchase

    Common Stock Purchase Warrant

    2024-08-27+3,00044,171 total(indirect: By entity)
    Exercise: $8.44From: 2024-08-27Exp: 2029-08-27Common Stock
Transactions
  • Purchase

    Common Stock Purchase Warrant

    2024-08-27+3,00044,171 total(indirect: By entity)
    Exercise: $8.44From: 2024-08-27Exp: 2029-08-27Common Stock
  • Purchase

    Common Stock

    2024-08-27$8.44/sh+30,000$253,200398,683 total(indirect: By entity)
Footnotes (3)
  • [F1]The reported securities are owned directly by Strome Mezzanine Fund II, LP ("SMF II).
  • [F2]Strome Investment Management, LP is the general partner of SMF II. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark E. Strome is the President and CEO of Strome Group, Inc. Mr. Strome, Strome Investment Management, LP and Strome Group, Inc. (together, the "Reporting Persons") may be deemed to share voting and investment power for and to beneficially own the shares held by SMF under Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act").
  • [F3]Pursuant to Rule 16a-1(a)(4) of the Exchange Act, this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.

Documents

1 file

Issuer

Zivo Bioscience, Inc.

CIK 0001101026

Entity typeother

Related Parties

1
  • filerCIK 0000919484

Filing Metadata

Form type
5
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 7:48 PM ET
Size
12.3 KB